- Home
- COHR vs VRNA Comparison
COHR vs VRNA Comparison
Compare COHR & VRNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COHR
- VRNA
- Stock Information
- Founded
- COHR 1971
- VRNA 2005
- Country
- COHR United States
- VRNA United Kingdom
- Employees
- COHR N/A
- VRNA N/A
- Industry
- COHR Electronic Components
- VRNA Biotechnology: Pharmaceutical Preparations
- Sector
- COHR Technology
- VRNA Health Care
- Exchange
- COHR Nasdaq
- VRNA Nasdaq
- Market Cap
- COHR 9.8B
- VRNA 7.8B
- IPO Year
- COHR 1987
- VRNA 2017
- Fundamental
- Price
- COHR $81.21
- VRNA $92.20
- Analyst Decision
- COHR Strong Buy
- VRNA Strong Buy
- Analyst Count
- COHR 16
- VRNA 7
- Target Price
- COHR $104.06
- VRNA $97.57
- AVG Volume (30 Days)
- COHR 2.7M
- VRNA 1.4M
- Earning Date
- COHR 08-14-2025
- VRNA 08-07-2025
- Dividend Yield
- COHR N/A
- VRNA N/A
- EPS Growth
- COHR N/A
- VRNA N/A
- EPS
- COHR N/A
- VRNA N/A
- Revenue
- COHR $5,595,041,000.00
- VRNA $118,535,000.00
- Revenue This Year
- COHR $25.33
- VRNA $891.79
- Revenue Next Year
- COHR $9.76
- VRNA $78.94
- P/E Ratio
- COHR N/A
- VRNA N/A
- Revenue Growth
- COHR 21.67
- VRNA N/A
- 52 Week Low
- COHR $45.58
- VRNA $14.14
- 52 Week High
- COHR $113.60
- VRNA $94.45
- Technical
- Relative Strength Index (RSI)
- COHR 56.57
- VRNA 78.05
- Support Level
- COHR $76.88
- VRNA $82.18
- Resistance Level
- COHR $83.90
- VRNA $93.74
- Average True Range (ATR)
- COHR 3.11
- VRNA 3.21
- MACD
- COHR -0.37
- VRNA 0.89
- Stochastic Oscillator
- COHR 73.23
- VRNA 92.52
About COHR Coherent Corp.
Coherent Corp engaged in materials, networking, and lasers, is a vertically integrated manufacturing company that develops, manufactures, and markets engineered materials, optoelectronic components and devices, and lasers for use in the industrial, communications, electronics and instrumentation markets. The firm operates in three segments Networking, Materials, and Lasers Segment. It generates maximum revenue from Networking segment. The company geographically operates in North America. Europe, China, Japan and Rest of the world.
About VRNA Verona Pharma plc
Verona Pharma PLC is a clinical-stage biopharmaceutical company focused on developing and commercializing therapeutics for the treatment of respiratory diseases with unmet medical needs. The company is currently focusing on developing its Ensifentrine product candidate, which will treat chronic obstructive pulmonary disease (COPD), cystic fibrosis (CF), and other respiratory diseases, including asthma.